Cargando…
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
Liquid biopsy with circulating free DNA (cfDNA) is a recommended alternative method of re-biopsy. Quality control with cfDNA is indispensable for precise examinations, and it is desirable to achieve high-quality cfDNA separation. We investigated two issues: the influence of pre-analytical procedures...
Autores principales: | Sato, Akemi, Nakashima, Chiho, Abe, Tomonori, Kato, Junichi, Hirai, Mitsuharu, Nakamura, Tomomi, Komiya, Kazutoshi, Kimura, Shinya, Sueoka, Eisaburo, Sueoka-Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112748/ https://www.ncbi.nlm.nih.gov/pubmed/30159131 http://dx.doi.org/10.18632/oncotarget.25881 |
Ejemplares similares
-
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
por: Nakashima, Chiho, et al.
Publicado: (2018) -
Origin of circulating free DNA in patients with lung cancer
por: Abe, Tomonori, et al.
Publicado: (2020) -
Mechanisms of acquired resistance to afatinib clarified with liquid biopsy
por: Nakamura, Tomomi, et al.
Publicado: (2018) -
Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
por: Komiya, Kazutoshi, et al.
Publicado: (2019) -
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
por: Komiya, Kazutoshi, et al.
Publicado: (2016)